Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2025-02-05 Notice of Dividend Amou…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the 'Decision on Shareholder Register Closure (Record Date) for Cash/In-Kind Dividends'. It specifies the record date for determining shareholders eligible for dividends. Since this is a formal regulatory announcement regarding dividend-related procedures rather than the dividend payment announcement itself (which is linked as a separate disclosure), it falls under the category of general regulatory filings.
2025-02-05 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Handok. It details the date, location, and specific agenda items for the upcoming meeting, including financial statement approval, director appointments, and stock option grants. This type of document is a standard proxy solicitation material provided to shareholders to inform them of meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement category.
2025-02-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of major shareholders and their special relations. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-12-27 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of convertible bonds by '어센트-IBKC 신기술사업투자조합 제2호' in '주식회사 한독'. This type of filing is specifically used to notify the market when an entity crosses a significant shareholding threshold (typically 5% or more). In the provided classification schema, this corresponds to a Major Shareholding Notification.
2024-12-16 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding the issuance of convertible bonds (전환사채권 발행결정). This type of filing is a standard regulatory disclosure for capital structure changes and financing activities in the Korean market. Since it details the terms, purpose, and conditions of a specific financing event (convertible bond issuance), it falls under the 'Capital/Financing Update' category.
2024-12-10 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and valuation methodology. This type of filing is a standard corporate disclosure regarding capital structure changes and equity-based compensation, which falls under the 'Share Issue/Capital Change' category in the provided schema.
2024-12-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.